Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in maternal serum alpha-fetoprotein screening.

J L Bock1

  • 1Department of Pathology, State University of New York, Stony Brook.

American Journal of Clinical Pathology
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The new era of automated immunoassay.

American journal of clinical pathology·2000
Same author

Cardiac troponin. How specific is specific?

American journal of clinical pathology·1999
Same author

Effects of several nonsteroidal antiinflammatory drugs on thyroid function tests.

The Journal of rheumatology·1999
Same author

Evaluation of CK-MB isoform analysis for early diagnosis of myocardial infarction.

The Journal of emergency medicine·1999
Same author

Cardiac marker point-of-care testing in the Emergency Department and Cardiac Care Unit.

Clinical chemistry·1998
Same author

Evaluation of cardiac STATus CK-MB/myoglobin device for rapidly ruling out acute myocardial infarction.

Clinics in laboratory medicine·1998
Same journal

Invasive urothelial carcinoma in association with surface low-grade papillary urothelial carcinoma: clinical and pathologic insights from a rare entity.

American journal of clinical pathology·2026
Same journal

CEACAM1 expression by immunohistochemistry in B-cell lymphomas and plasma cell myeloma.

American journal of clinical pathology·2026
Same journal

Comprehensive multicriteria life cycle assessment of biopsy processing in a surgical pathology department.

American journal of clinical pathology·2026
Same journal

Prognostic significance of Myb protein and its downstream target genes in lacrimal gland adenoid cystic carcinoma.

American journal of clinical pathology·2026
Same journal

Mismatch repair protein "nonclassic expression loss" pattern in colorectal cancer: an important staining pattern that is not well understood.

American journal of clinical pathology·2026
Same journal

Musculoskeletal pain in medical laboratory personnel: a cross-sectional study.

American journal of clinical pathology·2026
See all related articles

Maternal serum alpha-fetoprotein screening, initially for fetal neural tube defects, has evolved significantly. Modern methods offer improved accuracy and broader diagnostic insights for various conditions.

Area of Science:

  • Biochemistry and Obstetrics
  • Maternal and Fetal Health Screening

Background:

  • Maternal serum alpha-fetoprotein (MSAFP) testing emerged in the 1970s for screening neural tube defects.
  • Significant advancements in assay technology and interpretation have occurred since its inception.
  • MSAFP is recognized for its unique clinical and laboratory applications in prenatal diagnostics.

Purpose of the Study:

  • To review current procedures for maternal serum alpha-fetoprotein screening.
  • To summarize recent developments and advancements in MSAFP testing.
  • To highlight the evolving role of MSAFP in prenatal health assessment.

Main Methods:

  • Review of historical and current methodologies for MSAFP measurement.
  • Analysis of refined interpretation strategies for screening results.

Related Experiment Videos

  • Examination of advancements in follow-up testing protocols for identified risks.

    • Main Results:

    • Improved assay methods have enhanced the reliability of MSAFP screening.
    • Refined interpretation has led to more accurate risk assessment for fetal anomalies.
    • Discovery of additional disease associations beyond neural tube defects.

    Conclusions:

    • Maternal serum alpha-fetoprotein screening remains a vital tool in prenatal care.
    • Continuous evolution of testing and interpretation enhances its diagnostic utility.
    • The test's unique characteristics support its ongoing clinical importance.